GlassScriptPhysician profile
Yelena Lapkin
NPI 1497932487
$1,563.20
in general payments reported to CMS, 2019-2025
19 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $60.14 · 2021: $12.73 · 2022: $260 · 2023: $284 · 2024: $420 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $330.37 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $203.65 | 2023-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $189.34 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $138.66 | 2019-2023 | |
| Harrow Eye, LLC | $115.93 | 2024-2025 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $93.98 | 2019-2023 | Tecnis Simplicity, Tecnis Iol |
| Biotissue Holdings INC. | $88.73 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $74.45 | 2019-2021 | |
| Alcon Vision LLC | $64.00 | 2022-2025 | Tryptyr, Rocklatan |
| Visioneering Technologies, INC. | $51.89 | 2019 | |
| Ani Pharmaceuticals, INC. | $31.32 | 2024-2025 | Purified Cortrophin Gel |
| Dompe US, INC. | $30.56 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $28.56 | 2023 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $25.89 | 2025 | Omidria |
| Aerie Pharmaceuticals, INC. | $25.53 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $23.15 | 2024 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Horizon Therapeutics Plc | $16.64 | 2023 | Tepezza |
| Eyepoint US, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yelena Lapkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.